Drugs / Naoxintong Capsules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07698223 | Mar 2027 → Jun 2028 expected | diabetic kidney disease | Chen Xiangmei | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Naoxintong Capsules | “receive either Naoxintong Capsules or matching placebo” NCT07698223 ↗ |
| Known as | Naoxintong Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07698223 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “traditional Chinese medicine formulation” NCT07698223 ↗ |
| Route | Oral | “taken orally” NCT07698223 ↗ |